TTrialPathMatch Me to Trials
← Back to trials
RecruitingHypertension in PregnancyPostpartum PreeclampsiaPostpartum Complication

Rhode Island - Statewide Postpartum Hypertension Remote Surveillance

Eligible age

18–60 yrs

Accepts

Women

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in terms of persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.

Sponsor: Women and Infants Hospital of Rhode Island

You may qualify if…

  • Postpartum patient aged 18 years or more at any birthing hospital in Rhode Island
  • Diagnosed during pregnancy or after delivery with hypertensive disorder of pregnant
  • English-, Spanish-, Portuguese-, or Haitian-Creole-speaking
  • Smartphone ownership

You may not qualify if…

  • Prior enrollment in this trial
  • Prisoners or incarcerated people
  • Inability or unwillingness to provide informed consent
  • Inability to communicate with study team, despite an interpreter

Where it's recruiting

Rhode Island

Newport · Providence · Wakefield · Warwick

Source: ClinicalTrials.gov · NCT06842875 · last updated 2025-06-17